Difference between revisions of "NextGen-O2k"
From Bioblast
| Line 1: | Line 1: | ||
{{MitoFit highlights page name}} | {{MitoFit highlights page name}} | ||
<big><big>'''The revolutionary all-in-one device to conquer mitochondrial disease'''</big></big> | <big><big>'''The revolutionary all-in-one device to conquer mitochondrial disease'''</big></big> | ||
[[File:NextGen-O2k coverpage 2.png|1600px | [[File:NextGen-O2k coverpage 2.png|1600px]] | ||
<br /> | <br /> | ||
Revision as of 15:42, 6 April 2019
Template:MitoFit highlights page name
The revolutionary all-in-one device to conquer mitochondrial disease
NextGen-O2k H2020-SMEInst
- Horizon 2020 Framework Programme Proposal: 859770 — NextGen-O2k
- EIC-SMEInst-2018-2020 — SME instrument phase 2
- Duration of the action: 24 months
- Horizon 2020 Framework Programme Proposal: 859770 — NextGen-O2k
- High-resolution respirometry (HRR) and unique combinations of the O2k with
- Fluorometry: the O2k-FluoRespirometer
- Potentiometry: the O2k-pH ISE-Module and O2k-TPP+ ISE-Module
- Amperometric measurement of nitric oxide: the O2k-NO Amp-Module
- NextGen-O2k: extend HRR to the all-in-one device
- (+1) Cyclic voltammetry: the Q-redox sensor
- (+2) Controlled wavelengths and light intensity: PhotoBiology module
- High-resolution respirometry (HRR) and unique combinations of the O2k with
